Q: Can you please talk about hereditary optic neuropathy? I’m the fifth generation in my family to have it, and my daughter has now been diagnosed as well. I would like to know about any recent ...
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing ...
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
New data published in the Journal Science Translational Medicine shows encouraging results in a worldwide clinical trial for patients diagnosed with the neuro-degenerative blinding eye disease; Leber ...
GenSight Biologics has reported new data from its phase 3 program for GS010, its gene therapy for an ultrarare eye disease, sparking another uptick in its share price. The French biotech says the ...
Dear Doctors: Can you please talk about hereditary optic neuropathy? I’m the fifth generation in my family to have it, and my daughter has now been diagnosed as well. I would like to know about any ...
Q Can you please talk about hereditary optic neuropathy? I’m the fifth generation in my family to have it, and my daughter has now been diagnosed as well. I would like to know about any recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results